The discovery of a new mechanism of cell death in children with an ultra-rare genetic mutation has shed light on potential connections to other neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s. Researchers at the German research center, Helmholtz Munich, found that mutations in a specific gene led to inflammation and cell death in neurons in both mice and lab-grown human brain cells.
This unique form of cell death, known as ferroptosis, is triggered by iron accumulation and oxidative damage to the cell membrane. The researchers believe that this mechanism may be similar to cell death processes observed in dementia, with recent evidence suggesting a link to Alzheimer’s disease.
The genetic disorder in question, Sedaghatian-type spondylometaphyseal dysplasia (SSMD), is extremely rare and results in severe brain and skeletal abnormalities. Mutations in the gene encoding the enzyme GPX4 have been linked to SSMD, highlighting the enzyme’s role in protecting cell membranes from oxidative damage.
In lab experiments, researchers found that mutations in the GPX4 gene led to dysfunction in protecting neurons, ultimately causing cell death. By studying patients with SSMD and conducting experiments in mice and lab-grown brain cells, the team was able to uncover the impact of GPX4 mutations on cell survival.
Dr. Marcus Conrad, a cell biologist at Helmholtz Munich, likened the GPX4 enzyme to a surfboard that detoxifies lipid peroxides on the cell membrane. When the enzyme is mutated, it loses its ability to protect neurons, leading to vulnerability to ferroptosis.
Lab-grown neurons derived from SSMD patients were particularly sensitive to ferroptosis, but researchers were able to slow neural death by blocking the process with a chemical compound. This research highlights the importance of understanding cell membrane damage in neurodegenerative diseases like dementia.
While dementia is often associated with aging, rare genetic disorders like SSMD can cause cognitive decline in children. By studying these tragic cases, researchers gain valuable insights into the mechanisms of neurodegeneration and potential treatment strategies.
The study, published in the journal Cell, underscores the need for long-term funding for basic research and international collaboration to unravel the complexities of neurodegenerative diseases. By continuing to investigate rare genetic disorders like SSMD, scientists hope to uncover new strategies for combating dementia and other related conditions.
